MD MBA - Morphic Holding CFO COO

Insider

MD MBA is CFO COO of Morphic Holding
Age 48
Phone781 996 0955
Webhttps://www.morphictx.com

Morphic Holding Management Efficiency

The company has return on total asset (ROA) of (0.1909) % which means that it has lost $0.1909 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2669) %, meaning that it created substantial loss on money invested by shareholders. Morphic Holding's management efficiency ratios could be used to measure how well Morphic Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Morphic Holding currently holds 2.34 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Morphic Holding has a current ratio of 20.25, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Morphic Holding's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Sbastien DesprezImmunocore Holdings
N/A
Joan WoodStoke Therapeutics
N/A
Mike OuimettePliant Therapeutics
51
Johannes HullPliant Therapeutics
50
Rohan Palekar89bio Inc
59
Troy JDAvidity Biosciences
56
Martin MDVentyx Biosciences
49
Michael FlanaganAvidity Biosciences
62
Prof DavisAvidity Biosciences
N/A
Jack AndersRevolution Medicines
49
Rebecca MDMadrigal Pharmaceuticals
73
Dawn KalmarStoke Therapeutics
47
Michael MacLeanAvidity Biosciences
58
MBA MDPliant Therapeutics
56
MSc MBAInozyme Pharma
53
Brian MBAImmunocore Holdings
58
Path FRCPRevolution Medicines
61
MS MBAInozyme Pharma
48
Frank McCormickAvidity Biosciences
75
Robert WaltermireMadrigal Pharmaceuticals
60
MBA MBAInozyme Pharma
65
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. Morphic Holding (MORF) is traded on NASDAQ Exchange in USA and employs 128 people.

Management Performance

Morphic Holding Leadership Team

Elected by the shareholders, the Morphic Holding's board of directors comprises two types of representatives: Morphic Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morphic. The board's role is to monitor Morphic Holding's management team and ensure that shareholders' interests are well served. Morphic Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morphic Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, CFO COO
Farrell CPA, Sr Officer
Simon MBBS, Chief Officer
Joanne Gibbons, Senior Affairs
CPA Farrell, Senior Officer
Aaron Pelta, Senior Development
Dr MBA, Independent Founder
Bruce Rogers, President Officer
Praveen MD, MD CEO
Timothy Springer, Independent Founder
Blaise Lippa, Chief Officer
William Esq, General Secretary

Morphic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morphic Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Morphic Stock

If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.